|
|
|
|
Week 48 Safety and Efficacy of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced Women in the BRIGHTE Study
|
|
|
Reported by Jules Levin
CROI 2019 March 4-7 Seattle
R. Quercia,1 J. Slater,2 A. Clark,1 J. Aberg,3 J.-M. Molina,4 M. Koz
|
|
|
|
|
|
|